Olema Pharmaceuticals, Inc. (OLMA) Financials

OLMA Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 530.6 million 50.2 million
Dec. 31, 2025 533.4 million 54.9 million
Sept. 30, 2025 352.5 million 45.0 million
June 30, 2025 382.0 million 36.8 million

OLMA Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -46.0 million ?
Dec. 31, 2025 -38.3 million 4.3 million
Sept. 30, 2025 -34.5 million 4.3 million
June 30, 2025 -29.9 million 4.7 million

OLMA Net Income

No data available :(

OLMA Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 505.3 million - -
Dec. 31, 2025 505.4 million 69000 1.2 million
Sept. 30, 2025 329.0 million 3.0 million 1.5 million
June 30, 2025 361.9 million 3.0 million 1.8 million

OLMA Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 102.8 million
Dec. 31, 2025 91.3 million
Sept. 30, 2025 85.7 million
June 30, 2025 85.5 million

OLMA Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 - 49.2 million 8.6 million -119000
Dec. 31, 2025 - 43.2 million 6.9 million -
Sept. 30, 2025 - 40.0 million 5.9 million -
June 30, 2025 - 43.9 million 4.0 million -

OLMA Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 - 119000
Dec. 31, 2025 - 187000
Sept. 30, 2025 - -
June 30, 2025 - -

OLMA

Price: $10.51

52 week price:
3.89
36.26

Earnings Per Share: -2.03 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 106400

Market Capitalization: 1.2 billion

Links: